SG11201403326VA - Humanized light chain mice - Google Patents

Humanized light chain mice

Info

Publication number
SG11201403326VA
SG11201403326VA SG11201403326VA SG11201403326VA SG11201403326VA SG 11201403326V A SG11201403326V A SG 11201403326VA SG 11201403326V A SG11201403326V A SG 11201403326VA SG 11201403326V A SG11201403326V A SG 11201403326VA SG 11201403326V A SG11201403326V A SG 11201403326VA
Authority
SG
Singapore
Prior art keywords
light chain
humanized light
chain mice
mice
humanized
Prior art date
Application number
SG11201403326VA
Inventor
Lynn Macdonald
Cagan Gurer
Karolina A Hosiawa
Sean Stevens
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201403326VA publication Critical patent/SG11201403326VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201403326VA 2011-12-20 2012-12-17 Humanized light chain mice SG11201403326VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161578097P 2011-12-20 2011-12-20
PCT/US2012/069981 WO2013096142A1 (en) 2011-12-20 2012-12-17 Humanized light chain mice

Publications (1)

Publication Number Publication Date
SG11201403326VA true SG11201403326VA (en) 2014-07-30

Family

ID=47501484

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201913164YA SG10201913164YA (en) 2011-12-20 2012-12-17 Humanized light chain mice
SG11201403326VA SG11201403326VA (en) 2011-12-20 2012-12-17 Humanized light chain mice
SG10201605675WA SG10201605675WA (en) 2011-12-20 2012-12-17 Humanized light chain mice

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201913164YA SG10201913164YA (en) 2011-12-20 2012-12-17 Humanized light chain mice

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201605675WA SG10201605675WA (en) 2011-12-20 2012-12-17 Humanized light chain mice

Country Status (28)

Country Link
US (6) US9706759B2 (en)
EP (2) EP2793567B1 (en)
JP (4) JP6327750B2 (en)
KR (5) KR101924805B1 (en)
CN (1) CN104159444B (en)
AU (5) AU2012323987B2 (en)
BR (2) BR122021007339B1 (en)
CA (1) CA2859408C (en)
CY (1) CY1121638T1 (en)
DK (1) DK2793567T3 (en)
ES (1) ES2720186T3 (en)
HK (1) HK1202772A1 (en)
HR (1) HRP20190897T1 (en)
HU (1) HUE044266T2 (en)
IL (3) IL233153B (en)
IN (1) IN2014DN06094A (en)
LT (1) LT2793567T (en)
ME (1) ME03477B (en)
MX (2) MX356429B (en)
MY (1) MY173936A (en)
PL (1) PL2793567T3 (en)
PT (1) PT2793567T (en)
RS (1) RS58761B1 (en)
RU (2) RU2664181C2 (en)
SG (3) SG10201913164YA (en)
SI (1) SI2793567T1 (en)
TR (1) TR201903439T4 (en)
WO (1) WO2013096142A1 (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120204278A1 (en) 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
CN102638971B (en) 2009-07-08 2015-10-07 科马布有限公司 Animal model and treatment molecule
NZ707327A (en) 2010-08-02 2017-01-27 Regeneron Pharma Mice that make binding proteins comprising vl domains
CA2820824A1 (en) 2011-02-25 2012-10-18 Regeneron Pharmaceuticals, Inc. Adam6 mice
CN103917650B (en) 2011-08-05 2017-10-24 瑞泽恩制药公司 The universal light chain mouse of humanization
EP2758534B1 (en) 2011-09-19 2020-04-29 Kymab Limited Animals, repertoires & methods for the production of human antibodies
CA2846319A1 (en) 2011-09-19 2013-03-28 Kymab Limited Antibodies, variable domains & chains tailored for human use
EP2761008A1 (en) 2011-09-26 2014-08-06 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
SG10202010120XA (en) * 2011-10-17 2020-11-27 Regeneron Pharma Restricted immunoglobulin heavy chain mice
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
US20180295821A1 (en) * 2011-12-02 2018-10-18 Kymab Limited Transgenic Animals
GB201122047D0 (en) 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
SG10201913164YA (en) 2011-12-20 2020-03-30 Regeneron Pharma Humanized light chain mice
DK2809150T3 (en) * 2012-02-01 2019-12-09 Regeneron Pharma Humanized mice expressing heavy chains containing VL domains
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
US10251377B2 (en) 2012-03-28 2019-04-09 Kymab Limited Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
KR102381716B1 (en) 2012-06-12 2022-04-01 리제너론 파마슈티칼스 인코포레이티드 Humanized non-human animals with restricted immunoglobulin heavy chain loci
ES2678221T3 (en) 2013-02-20 2018-08-09 Regeneron Pharmaceuticals, Inc. Non-human animals with modified immunoglobulin heavy chain sequences
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
US9783618B2 (en) 2013-05-01 2017-10-10 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US9783593B2 (en) 2013-05-02 2017-10-10 Kymab Limited Antibodies, variable domains and chains tailored for human use
US11707056B2 (en) 2013-05-02 2023-07-25 Kymab Limited Animals, repertoires and methods
AU2014330922A1 (en) 2013-10-01 2016-03-03 Kymab Limited Animal models and therapeutic molecules
CA2941514A1 (en) 2014-03-21 2015-09-24 Regeneron Pharmaceuticals, Inc. Vl antigen binding proteins exhibiting distinct binding characteristics
CN106255410B (en) 2014-03-21 2020-01-10 瑞泽恩制药公司 Non-human animals producing single domain binding proteins
JP2018508224A (en) 2015-03-19 2018-03-29 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Non-human animals that select light chain variable regions that bind antigen
RU2018110364A (en) * 2015-08-24 2019-09-26 Трианни, Инк. IMPROVED PRODUCTION OF IMMUNOGLOBULINS
EP3384030A4 (en) 2015-12-03 2019-07-03 Trianni, Inc. Enhanced immunoglobulin diversity
CA3022997C (en) 2016-05-20 2023-07-18 Regeneron Pharmaceuticals, Inc. Methods for breaking immunological tolerance using multiple guide rnas
WO2017214089A1 (en) * 2016-06-06 2017-12-14 Regeneron Pharmaceuticals, Inc. Non-human animals expressing antibodies with human lambda light chains
MA44091A (en) * 2016-11-04 2018-10-24 Regeneron Pharma NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN LAMBDA LIGHT CHAIN LOCUS
SG10202109874VA (en) * 2017-01-19 2021-10-28 Open Monoclonal Tech Inc Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci
WO2018226861A1 (en) 2017-06-07 2018-12-13 Regeneron Pharmaceuticals, Inc. Compositions and methods for internalizing enzymes
HUE060608T2 (en) * 2017-12-05 2023-03-28 Regeneron Pharma Mice having an engineered immunoglobulin lambda light chain and uses thereof
BR112020019026A2 (en) * 2018-03-24 2020-12-29 Regeneron Pharmaceuticals, Inc. GENETICALLY MODIFIED NON-HUMAN ANIMAL, METHODS FOR PRODUCING GENETICALLY MODIFIED NON-HUMAN ANIMAL, FOR GENERATION OF AN ANTIGEN-BINDING PROTEIN, FOR OBTAINING A NUCLEIC ACID, AND FOR OBTAINING A CELL THAT EXPRESSES AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN HUMAN IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN AND/OR HUMAN IMMUNOGLOBULIN, IN VITRO METHOD OF PRODUCTION OF HUMAN IMMUNOGLOBULIN VARIABLE DOMAIN, NUCLEIC ACID, HOST CELL, ISOLATED CELL, AND HUMINOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN
EP3793591A1 (en) 2018-05-17 2021-03-24 Regeneron Pharmaceuticals, Inc. Anti-cd63 antibodies, conjugates, and uses thereof
CN109359045B (en) * 2018-10-16 2022-01-04 武汉斗鱼网络科技有限公司 Test method, device, equipment and storage medium
JP2020146318A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146309A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146310A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146305A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146313A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146316A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146298A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146304A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146307A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146303A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146315A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146308A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146311A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146317A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146297A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146300A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146302A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146314A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146306A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146299A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
JP2020146301A (en) * 2019-03-14 2020-09-17 株式会社三洋物産 Game machine
EP3979790A1 (en) * 2019-06-05 2022-04-13 Regeneron Pharmaceuticals, Inc. Non-human animals having a limited lambda light chain repertoire expressed from the kappa locus and uses thereof
WO2021003152A1 (en) * 2019-07-01 2021-01-07 Trianni, Inc. Transgenic mammals and methods of use thereof
EP3785536B1 (en) * 2019-08-28 2022-01-26 Trianni, Inc. Adam6 knockin mice
WO2022056276A1 (en) 2020-09-11 2022-03-17 Regeneron Pharmaceuticals, Inc. Identification and production of antigen-specific antibodies
DE112021004173T5 (en) 2020-10-02 2023-06-01 Nichia Corporation LIGHT SOURCE DEVICE AND LIGHT GUIDE ARRAY UNIT
JP2024500399A (en) 2020-12-16 2024-01-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Mice expressing humanized Fc alpha receptors
EP4326765A1 (en) 2021-04-20 2024-02-28 Regeneron Pharmaceuticals, Inc. Human antibodies to artemin and methods of use thereof
WO2024015816A1 (en) 2022-07-12 2024-01-18 Regeneron Pharmaceuticals, Inc. Antibodies to ciliary neurotrophic factor receptor (cntfr) and methods of use thereof

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
WO1991000906A1 (en) 1989-07-12 1991-01-24 Genetics Institute, Inc. Chimeric and transgenic animals capable of producing human antibodies
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US7041871B1 (en) * 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
DK1471142T3 (en) 1991-04-10 2009-03-09 Scripps Research Inst Heterodimeric receptor libraries using phagemids
AU669124B2 (en) 1991-09-18 1996-05-30 Kyowa Hakko Kirin Co., Ltd. Process for producing humanized chimera antibody
EP0746609A4 (en) * 1991-12-17 1997-12-17 Genpharm Int Transgenic non-human animals capable of producing heterologous antibodies
JPH08503617A (en) 1992-12-01 1996-04-23 プロテイン デザイン ラブズ、インコーポレーテッド Humanized antibody reactive with L-selectin
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US6632976B1 (en) 1995-08-29 2003-10-14 Kirin Beer Kabushiki Kaisha Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene
EP0907726A4 (en) 1996-06-26 2001-11-07 Baylor College Medicine Chromosomal rearrangement by insertion of two recombination substrates
KR100942002B1 (en) 1996-12-03 2010-02-12 암젠 프레몬트 인코포레이티드 Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
CN1203922A (en) 1997-03-21 1999-01-06 三共株式会社 Humanized anti-human fas antibody
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
US6147275A (en) * 1998-03-30 2000-11-14 Research Development Foundation Corticotropin releasing factor receptor 1-deficient mice
GB9823930D0 (en) 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
RU10506U1 (en) 1999-04-08 1999-08-16 Кривулин Виталий Николаевич MANUAL CULTIVATOR
JP2003501016A (en) 1999-05-27 2003-01-14 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ADAM polynucleotides and polypeptides
GB0001448D0 (en) 2000-01-21 2000-03-08 Novartis Ag Organic compounds
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
PT1354034E (en) 2000-11-30 2008-02-28 Medarex Inc Transgenic transchromosomal rodents for making human antibodies
TWI255272B (en) 2000-12-06 2006-05-21 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
GB0031284D0 (en) 2000-12-21 2001-01-31 Ks Biomedix Ltd High affinity antibodies
US7034134B2 (en) 2001-04-26 2006-04-25 Bristol-Myers Squibb Company Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29
CN100448992C (en) 2001-05-11 2009-01-07 麒麟医药株式会社 Artificial human chromosome containing human antibody lambda light chain gene
US7473557B2 (en) 2001-06-06 2009-01-06 Regeneron Pharmaceuticals, Inc. Method for targeting transcriptionally active loci
GB0115256D0 (en) 2001-06-21 2001-08-15 Babraham Inst Mouse light chain locus
DK1399484T3 (en) 2001-06-28 2010-11-08 Domantis Ltd Double-specific ligand and its use
WO2003031656A1 (en) 2001-10-05 2003-04-17 United States Environmental Protection Agency Genetic testing for male factor infertility
US20060199204A1 (en) 2001-10-05 2006-09-07 U.S. Epa Genetic testing for male factor infertility
EP1461442B1 (en) 2001-11-30 2017-09-06 Amgen Fremont Inc. Transgenic animals bearing human ig lambda light chain genes
US20030217171A1 (en) 2002-05-17 2003-11-20 Von Stuermer Wolfgang R. Self-replicating and self-installing software apparatus
JP4099646B2 (en) 2002-06-04 2008-06-11 株式会社安川電機 Voice coil motor
EP1517921B1 (en) 2002-06-28 2006-06-07 Domantis Limited Dual specific ligands with increased serum half-life
CA2965865C (en) 2002-07-18 2021-10-19 Merus N.V. Recombinant production of mixtures of antibodies
GB0228210D0 (en) 2002-12-03 2003-01-08 Babraham Inst Single chain antibodies
JP2006523090A (en) 2002-12-27 2006-10-12 ドマンティス リミテッド Bispecific single domain antibody specific for ligand and for ligand receptor
GB0230203D0 (en) 2002-12-27 2003-02-05 Domantis Ltd Fc fusion
GB0230201D0 (en) 2002-12-27 2003-02-05 Domantis Ltd Retargeting
GB2398784B (en) 2003-02-26 2005-07-27 Babraham Inst Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
CA2532117C (en) 2003-07-15 2012-07-10 Therapeutic Human Polyclonals, Inc. Humanized immunoglobulin loci
CN1605628A (en) 2003-09-03 2005-04-13 中国疾病预防控制中心病毒病预防控制所 Human source anti-hepatitis A virus gene engineering antibody from CHO cell
RU2251699C1 (en) 2003-09-25 2005-05-10 Киселев Всеволод Иванович Method for early and preclinical diagnostics of cervical cancer
CA2827654C (en) 2004-10-19 2019-04-02 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
ATE416465T1 (en) 2005-06-30 2008-12-15 Borealis Tech Oy COVERING LAYER FOR POWER OR COMMUNICATION CABLES
GB0618345D0 (en) 2006-09-18 2006-10-25 Univ Erasmus Binding molecules
CA2638117A1 (en) 2006-01-25 2007-08-30 Erasmus University Medical Center Rotterdam Generation of heavy-chain only antibodies in transgenic animals
GB0615327D0 (en) 2006-03-30 2006-09-13 Univ Edinburgh Culture medium containing kinase inhibitors and uses thereof
AU2007235496B2 (en) 2006-03-31 2013-11-21 E. R. Squibb & Sons, L.L.C. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
PT2374818E (en) 2006-06-02 2013-02-13 Regeneron Pharma High affinity antibodies to human il-6 receptor
WO2008022391A1 (en) 2006-08-22 2008-02-28 G2 Inflammation Pty Ltd Method for producing antibodies
ES2466669T3 (en) 2006-10-02 2014-06-10 Regeneron Pharmaceuticals, Inc. Human antibodies with high affinity for the human IL-4 receptor
RU2448979C2 (en) 2006-12-14 2012-04-27 Ридженерон Фармасьютикалз, Инк. Human antibodies to delta-like human ligand-4
JP5588866B2 (en) 2007-08-10 2014-09-10 メダレックス エル．エル．シー． HCO 32 and HCO 27 and related examples
US7659842B2 (en) 2007-10-24 2010-02-09 Infineon Technologies Ag Quantization error reduction in PWM full-MASH converters
EP2271758B1 (en) 2008-04-14 2018-09-12 Innovative Targeting Solutions Inc. Sequence diversity generation in immunoglobulins
CA2725169A1 (en) 2008-05-23 2009-11-26 Aliva Biopharmaceuticals, Inc. Method of generating single vl domain antibodies in transgenic animals
KR102362774B1 (en) 2008-09-30 2022-02-15 아블렉시스, 엘엘씨 Non-human mammals for the production of chimeric antibodies
DK2379727T3 (en) 2008-12-18 2017-01-16 Univ Erasmus Med Ct Rotterdam NON-HUMAN TRANSGENE ANIMALS EXPRESSING HUMANIZED ANTIBODIES AND USE THEREOF
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
CN102638971B (en) 2009-07-08 2015-10-07 科马布有限公司 Animal model and treatment molecule
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
US20120204278A1 (en) 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
DK2509409T3 (en) 2009-12-10 2016-11-14 Regeneron Pharma MICE, WHICH PRODUCES HEAVY CHAIN ANTIBODIES
US20120021409A1 (en) 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
HUE026229T2 (en) 2010-02-08 2016-06-28 Regeneron Pharma Common light chain mouse
NZ605966A (en) 2010-06-17 2015-04-24 Kymab Ltd Animal models and therapeutic molecules
NZ707198A (en) 2010-06-22 2016-04-29 Regeneron Pharma Mice expressing a light chain with human lambda variable and mouse constant regions
NZ707327A (en) 2010-08-02 2017-01-27 Regeneron Pharma Mice that make binding proteins comprising vl domains
WO2012063048A1 (en) 2010-11-08 2012-05-18 Kymab Limited Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
CA2820824A1 (en) 2011-02-25 2012-10-18 Regeneron Pharmaceuticals, Inc. Adam6 mice
CN103917650B (en) 2011-08-05 2017-10-24 瑞泽恩制药公司 The universal light chain mouse of humanization
EP2758534B1 (en) 2011-09-19 2020-04-29 Kymab Limited Animals, repertoires & methods for the production of human antibodies
CA2846319A1 (en) 2011-09-19 2013-03-28 Kymab Limited Antibodies, variable domains & chains tailored for human use
EP2761008A1 (en) 2011-09-26 2014-08-06 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
SG10202010120XA (en) 2011-10-17 2020-11-27 Regeneron Pharma Restricted immunoglobulin heavy chain mice
GB2496375A (en) 2011-10-28 2013-05-15 Kymab Ltd A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
GB201122047D0 (en) 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
SG10201913164YA (en) 2011-12-20 2020-03-30 Regeneron Pharma Humanized light chain mice
DK2809150T3 (en) 2012-02-01 2019-12-09 Regeneron Pharma Humanized mice expressing heavy chains containing VL domains
US9788534B2 (en) 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules

Also Published As

Publication number Publication date
RS58761B1 (en) 2019-06-28
KR102038974B1 (en) 2019-10-31
MY173936A (en) 2020-02-27
ES2720186T3 (en) 2019-07-18
CA2859408C (en) 2020-06-16
CN104159444A (en) 2014-11-19
AU2012323987B2 (en) 2015-07-09
JP2020168014A (en) 2020-10-15
NZ627211A (en) 2016-03-31
KR20200108113A (en) 2020-09-16
BR112014015238B1 (en) 2022-11-16
US11617357B2 (en) 2023-04-04
US20200221676A1 (en) 2020-07-16
KR20200021552A (en) 2020-02-28
RU2014127339A (en) 2016-02-10
US9706759B2 (en) 2017-07-18
SG10201605675WA (en) 2016-09-29
AU2015238803A1 (en) 2015-10-29
AU2020201596B2 (en) 2022-05-26
RU2664181C2 (en) 2018-08-15
US20170332609A1 (en) 2017-11-23
SI2793567T1 (en) 2019-05-31
JP6327750B2 (en) 2018-05-23
KR102081657B1 (en) 2020-02-26
KR20190124339A (en) 2019-11-04
WO2013096142A1 (en) 2013-06-27
HUE044266T2 (en) 2019-10-28
US20130160153A1 (en) 2013-06-20
SG10201913164YA (en) 2020-03-30
CA2859408A1 (en) 2013-06-27
IL258561B (en) 2019-05-30
TR201903439T4 (en) 2019-04-22
HK1202772A1 (en) 2015-10-09
US10561124B2 (en) 2020-02-18
IL258561A (en) 2018-05-31
EP2793567B1 (en) 2019-02-27
PL2793567T3 (en) 2019-09-30
MX2021000298A (en) 2022-06-08
AU2012323987A1 (en) 2013-07-04
HRP20190897T1 (en) 2019-09-20
AU2017251797A1 (en) 2017-11-16
AU2017251797B2 (en) 2019-12-05
US20230337646A1 (en) 2023-10-26
US20140017228A1 (en) 2014-01-16
RU2018119366A (en) 2018-11-09
US9622459B2 (en) 2017-04-18
LT2793567T (en) 2019-04-10
KR102156139B1 (en) 2020-09-15
AU2020201596A1 (en) 2020-03-19
IN2014DN06094A (en) 2015-08-14
KR20140116135A (en) 2014-10-01
RU2018119366A3 (en) 2021-10-06
JP2017046722A (en) 2017-03-09
JP6728308B2 (en) 2020-07-22
ME03477B (en) 2020-01-20
IL233153B (en) 2018-04-30
IL266268A (en) 2019-06-30
JP7152447B2 (en) 2022-10-12
JP2015502177A (en) 2015-01-22
EP2793567A1 (en) 2014-10-29
KR102186822B1 (en) 2020-12-04
AU2015238803B2 (en) 2017-11-16
MX356429B (en) 2018-05-29
US11612151B2 (en) 2023-03-28
PT2793567T (en) 2019-05-27
US20200221675A1 (en) 2020-07-16
MX2014007682A (en) 2015-05-11
EP3527070A1 (en) 2019-08-21
JP2022180594A (en) 2022-12-06
KR20180132938A (en) 2018-12-12
CN104159444B (en) 2017-09-01
BR112014015238A2 (en) 2020-12-29
KR101924805B1 (en) 2018-12-04
JP2019047806A (en) 2019-03-28
CY1121638T1 (en) 2020-07-31
IL233153A0 (en) 2014-07-31
RU2761639C2 (en) 2021-12-13
DK2793567T3 (en) 2019-04-15
AU2022221449A1 (en) 2022-11-24
BR122021007339B1 (en) 2022-11-29
IL266268B (en) 2020-05-31

Similar Documents

Publication Publication Date Title
IL266268B (en) Humanized light chain mice
IL273982A (en) Humanized universal light chain mice
IL292030B1 (en) Restricted immunoglobulin heavy chain mice